Candesartan Cilexetil And Hydrochlorothiazide recalls
Candesartan Cilexetil And Hydrochlorothiazide products have been recalled 1 time, most recently on 28 Oct 2020. The recalling company is usually Mylan Pharmaceuticals. The most common reason is potency & assay.
Total recalls1since 2020
Last 12 months0reported
Class I00% of total
Ongoing0latest 28 Oct 2020
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 0 0%Class III 1 100%
Why candesartan cilexetil and hydrochlorothiazide is recalled
Companies
Product types
By year
All candesartan cilexetil and hydrochlorothiazide recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Candesartan Cilexetil and Hydrochlorothiazide Tablets recalledCandesartan Cilexetil And Hydrochlorothiazide | Mylan Pharmaceuticals | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.